References
- Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 2009;50:1294–306.
- Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838–51.
- Kawada N. Evolution of hepatic fibrosis research. Hepatol Res 2011;41:199–208.
- Xu R, Zhang Z, Wang FS. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol 2012;9:296–301.
- Osawa Y, Hoshi M, Yasuda I, Saibara T, Moriwaki H, Kozawa O. Tumor necrosis factor-alpha promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PLoS ONE 2013;8:e65251.
- Trifan A, Sfarti C, Cojocariu C, et al. Increased liver stiffness in extrahepatic cholestasis caused by choledocholithiasis. Hepat Mon 2011;11:372–5.
- Hashash JG, Proksell S, Behari J. An unusual cause of cholestasis after liver transplantation. Sarcoidosis. Gastroenterology 2013;145:e9–10.
- Weerachayaphorn J, Luo Y, Mennone A, Soroka CJ, Harry K, Boyer JL. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice. J Hepatol 2014;60:160–6.
- Fickert P, Pollheimer MJ, Silbert D, et al. Differential effects of norUDCA and UDCA in obstructive cholestasis in mice. J Hepatol 2013;58:1201–8.
- Beck PL, Lee SS. Vitamin K1 improves survival in bile-duct-ligated rats with cirrhosis. J Hepatol 1995;23:235.
- Fujiwara K, Ogata I, Ohta Y, et al. Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver. Hepatology 1988;8:804–7.
- Georgiev P, Jochum W, Heinrich S, et al. Characterization of time-related changes after experimental bile duct ligation. Br J Surg 2008;95:646–56.
- Su CW, Chan CC, Hung HH, et al. Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis. J Clin Gastroenterol 2009;43:876–83.
- Roderburg C, Luedde M, Vargas CD, et al. miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 2013;58:736–42.
- Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest 2013;123:1887–901.
- Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209–18.
- Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988;8:1027–33.
- Reau NS, Jensen DM. Vanishing bile duct syndrome. Clin Liver Dis 2008;12:203–17.
- Jonker JW, Liddle C, Downes M. FXR and PXR: potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol 2012;130:147–58.